Dr. Mohammed A. Ali, M.D.,
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Years since graduation
- 25
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 349
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
FL license ME127983
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Josephs Hospital Tampa, FL
Medical groups
- American Arthritis and Rheumatology Associates LLC (65 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 349
- Services billed
- 96,969
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 51,200 | 16 |
| Injection, romosozumab-aqqg, 1 mg | 12,810 | 12 |
| Injection, denosumab, 1 mg | 3,240 | 32 |
| Established patient office or other outpatient visit, 30-39 minutes | 573 | 240 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 371 | 53 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 300 | 56 |
| Established patient office or other outpatient visit, 20-29 minutes | 190 | 132 |
| Administration of chemotherapy into vein, 1 hour or less | 119 | 19 |
| Infusion, normal saline solution, 250 cc | 104 | 17 |
| Injection, zoledronic acid, 1 mg | 85 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tramadol Hcl Other prescribers in Tampa, FL | 310 |
| Hydroxychloroquine Sulfate Other prescribers in Tampa, FL | 251 |
| Prednisone Other prescribers in Tampa, FL | 211 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Tampa, FL | 195 |
| Gabapentin Other prescribers in Tampa, FL | 183 |
| Methotrexate (methotrexate sodium) Other prescribers in Tampa, FL | 165 |
| Pregabalin Other prescribers in Tampa, FL | 124 |
| Leflunomide Other prescribers in Tampa, FL | 119 |
| Meloxicam Other prescribers in Tampa, FL | 90 |
| Celecoxib Other prescribers in Tampa, FL | 84 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 22 companies reported 131 payments worth $2,758 in total to this clinician.
| AbbVie Inc. | $405 |
|---|---|
| Amgen Inc. | $273 |
| AstraZeneca Pharmaceuticals LP | $250 |
| UCB, Inc. | $234 |
| Ani Pharmaceuticals, Inc. | $217 |
| Pfizer Inc. | $205 |
| Mallinckrodt Hospital Products Inc. | $168 |
| Janssen Biotech, Inc. | $153 |
| Food and Beverage | $2,658 |
|---|---|
| Education | $99.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Jun 4, 2025 | Education TREMFYA · Immunology · in-kind | $99.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.